-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Oyster Point Pharma, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2019 to Q1 2022.
- Oyster Point Pharma, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2022 was -$85K, a 75% increase year-over-year.
- Oyster Point Pharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$1.49M, a 112% decline from 2020.
- Oyster Point Pharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2020 was -$700K, a 250% decline from 2019.
- Oyster Point Pharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2019 was -$200K.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)